Article
ERBB4 deficiency promotes atrial myopathy underlying the atrial fibrillation substrate
2026-05-27
Abstract excerpt
<h4>Background</h4> Atrial fibrillation (AF) is a leading cause of stroke, cardiovascular morbidity, and mortality. Atrial myopathy, characterized by progressive metabolic, electrical, and structural changes, creates the arrhythmogenic substrate that drives AF. Defining the key drivers of atrial myopathic processes is essential for targeted therapies that can mitigate AF progression. Here we explore how reduced E...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6a452310-0a98-530f-8b1c-589effab8a2e
- DOI
- 10.64898/2026.05.26.26354173
